Arovella Therapeutics Limited (ASX:ALA)
Australia flag Australia · Delayed Price · Currency is AUD
0.0890
+0.0040 (4.71%)
Feb 19, 2026, 4:10 PM AEST

Arovella Therapeutics Balance Sheet

Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Cash & Equivalents
20.8812.715.186.076.72
Cash & Short-Term Investments
20.8812.715.186.076.72
Cash Growth
64.20%145.67%-14.75%-9.62%587.20%
Accounts Receivable
--0.010.040.01
Other Receivables
0.110.18000.52
Receivables
0.110.180.010.040.53
Prepaid Expenses
0.110.210.030.060.09
Other Current Assets
0.070.050.20.42-
Total Current Assets
21.1713.155.426.597.34
Property, Plant & Equipment
0.430.130.050.370.43
Other Intangible Assets
---0.130.13
Long-Term Deferred Charges
---2.122.78
Total Assets
21.613.285.479.2110.69
Accounts Payable
0.940.980.770.750.23
Accrued Expenses
0.130.080.30.280.2
Current Portion of Leases
---0.070.08
Current Unearned Revenue
-0.140.150.340.2
Other Current Liabilities
0.420.840.450.061
Total Current Liabilities
1.492.041.681.511.69
Long-Term Leases
---0.080
Other Long-Term Liabilities
0.030.020.010.010.01
Total Liabilities
1.522.061.691.61.71
Common Stock
120.13104.388.8783.5477
Retained Earnings
-102.84-95.51-87.06-77.02-68.47
Comprehensive Income & Other
2.792.441.961.110.45
Total Common Equity
20.0811.233.787.628.98
Shareholders' Equity
20.0811.233.787.628.98
Total Liabilities & Equity
21.613.285.479.2110.69
Total Debt
---0.140.08
Net Cash (Debt)
20.8812.715.185.936.64
Net Cash Growth
64.20%145.67%-12.67%-10.72%644.16%
Net Cash Per Share
0.020.010.010.010.02
Filing Date Shares Outstanding
1,1891,051849.91669.84480.82
Total Common Shares Outstanding
1,1891,051849.91669.84480.82
Working Capital
19.6811.113.745.085.65
Book Value Per Share
0.020.010.000.010.02
Tangible Book Value
20.0811.233.787.488.85
Tangible Book Value Per Share
0.020.010.000.010.02
Machinery
0.710.340.251.071.19
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.